Loading clinical trials...
Loading clinical trials...
High-risk type human papillomavirus (HPV) is the known etiological agent of cervical cancer. HPV testing and risk stratification by genotyping has been recognized as an effective cervical screening pr...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Chang Gung Memorial Hospital
Collaborators
NCT07550010 · Human Papillomavirus Infection, Cervical Intraepithelial Neoplasia Grade 2 (CIN2), and more
NCT07493824 · Persistent HR-HPV Infection of the Cervix
NCT04226313 · Cervical Cancer, Cervical Dysplasia, and more
NCT04712851 · Cervical Intraepithelial Neoplasia, Cervical Squamous Cell Carcinoma In Situ, and more
NCT07428330 · Cervix Cancer, HIV Infections, and more
Changhua Christian Hospital
Changhua
Mackay Memorial Hospital
Taipei
Cathay General Hospital
Taipei
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions